日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Author Correction: O-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancer

作者更正:MITF 的 O-GlcNAc 化修饰调控其活性及乳腺癌中 CDK4/6 抑制剂的耐药性

Zhang, Yi; Zhou, Shuyan; Kai, Yan; Zhang, Ya-Qin; Peng, Changmin; Li, Zhuqing; Mughal, Muhammad Jameel; Julie, Belmar; Zheng, Xiaoyan; Ma, Junfeng; Ma, Cynthia X; Shen, Min; Hall, Matthew D; Li, Shunqiang; Zhu, Wenge

Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial

新辅助帕博西尼联合阿那曲唑治疗内分泌耐药的雌激素受体阳性/HER2阴性乳腺癌疗效的生物标志物:一项II期试验

Kong, Tim; Mabry, Alex; Highkin, Maureen; Wang, Anthony Z; Hoog, Jeremy; Guo, Zhanfang; Gonzales-Gonzales, Adrian; Thomas, Shana; Song, Yingduo; Gao, Feng; Opyrchal, Mateusz; Peterson, Lindsay; Ademuyiwa, Foluso; Margenthaler, Julie; Aft, Rebecca; Glover-Collins, Katherine; Nehring, Leslie; Tao, Yu; Sanati, Souzan; Hagemann, Ian S; Boulos, Fouad; Holt, Matthew; Ding, Li; Zhu, Wenge; Oh, Stephen T; Wang, Jianxin; Witkiewicz, Agnieszka K; Knudsen, Erik S; Bose, Ron; Weber, Jason D; Goetz, Matthew; Northfelt, Donald; Luo, Jingqin; Ma, Cynthia X

Stabilization of RUNX1 Induced by O-GlcNAcylation Promotes PDGF-BB-Mediated Resistance to CDK4/6 Inhibitors in Breast Cancer.

O-GlcNAc糖基化诱导的RUNX1稳定化促进PDGF-BB介导的乳腺癌对CDK4/6抑制剂的耐药性。

Zhou Shuyan, Zhang Yi, Belmar Julie, Hou Chunyan, Zhang Yaqin, Peng Changmin, Meng Yunxiao, Li Zhuqing, Mughal Muhammad Jameel, Gao Yanjun, Seto Edward, Shen Min, Hall Matthew D, Ma Junfeng, Ma Cynthia X, Li Shunqiang, Zhu Wenge

TFAP2C-DDR1 axis regulates resistance to CDK4/6 inhibitor in breast cancer.

TFAP2C-DDR1轴调控乳腺癌对CDK4/6抑制剂的耐药性

Mughal Muhammad Jameel, Zhang Yi, Li Zhuqing, Zhou Shuyan, Peng Changmin, Zhang Ya-Qin, Seto Edward, Shen Min, Hall Matthew D, Zhu Wenge

Systematic pan-cancer analysis reveals OGT and OGA as potential biomarkers for tumor microenvironment and therapeutic responses

系统性泛癌分析表明,OGT 和 OGA 可作为肿瘤微环境和治疗反应的潜在生物标志物。

Hou, Chunyan; Wu, Ci; Zhu, Wenge; Pei, Huadong; Ma, Junfeng

And-1 O-GlcNAcylation regulates homologous recombination repair and radioresistance in colorectal cancer

And-1 O-GlcNAc糖基化调控结直肠癌的同源重组修复和放射抗性

Zhou, Yuan; Zhang, Yi; Peng, Changmin; Li, Zhuqing; Pei, Huadong; Pei, Haiping; Zhu, Wenge

A questionnaire study on the knowledge, attitudes, and practices of fluid replacement and urination among Chinese elite athletes

一项关于中国精英运动员补液和排尿知识、态度和行为的问卷调查

Song, Ge; Yan, Yi; Zhao, Haotian; Chen, Junying; Deng, Yimin; Zhu, Wenge; Sun, Lingyu; Ma, Guansheng

Correlation between CT images of lateral plateau and lateral meniscus injuries in patients with Schatzker II tibial plateau fractures:a retrospective study

Schatzker II型胫骨平台骨折患者外侧平台损伤与外侧半月板损伤的CT影像相关性:一项回顾性研究

Pu, Ying; Lei, Zhu; Wenge, Ding; Yue, Xu; Xiaowei, Jiang; Kejie, Wang; Yiwen, Zhao; Zhihui, Huang; Xiaoyu, Dai

Identification of potent SENP1 inhibitors that inactivate SENP1/JAK2/STAT signaling pathway and overcome platinum drug resistance in ovarian cancer

鉴定能够抑制SENP1/JAK2/STAT信号通路并克服卵巢癌铂类药物耐药性的强效SENP1抑制剂

Zhang, Yi; Wei, Huiqiang; Zhou, Yuan; Li, Zhuqing; Gou, Wenfeng; Meng, Yunxiao; Zheng, Wei; Li, Jing; Li, Yiliang; Zhu, Wenge

DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer

DUOXA1介导的ROS生成通过激活ATR-Chk1通路促进卵巢癌的顺铂耐药性

Meng, Yunxiao; Chen, Chi-Wei; Yung, Mingo M H; Sun, Wei; Sun, Jing; Li, Zhuqing; Li, Jing; Li, Zongzhu; Zhou, Wei; Liu, Stephanie S; Cheung, Annie N Y; Ngan, Hextan Y S; Braisted, John C; Kai, Yan; Peng, Weiqun; Tzatsos, Alexandros; Li, Yiliang; Dai, Zhijun; Zheng, Wei; Chan, David W; Zhu, Wenge